-
Desert Hope Treatment Center Launches First Responder Lifeline Program, Offering Confidential Care for Frontline Heroes
LAS VEGAS, June 18, 2026 (GLOBE NEWSWIRE) — Desert Hope Treatment Center, a leading addiction treatment center in Las Vegas, has introduced its First Responder Lifeline Program, designed specifically for law enforcement officers, firefighters, EMTs, dispatchers, corrections officers, and other public safety professionals. The program was developed in collaboration with public safety leaders, including representatives…
-
OVIOS Launches Fire Pit Conversation Collection Ahead of Father’s Day
LOS ANGELES, CA, June 18, 2026 (GLOBE NEWSWIRE) — As Father’s Day approaches, OVIOS has launched its Fire Pit Conversation Collection, a new outdoor furniture collection designed to help families create more comfortable, inviting, and experience-centered backyard spaces for celebrating dads. The launch comes as more American families are rethinking traditional Father’s Day gifting. Instead…
-
eimmigration Launches Heroes Spotlight to Recognize the Top Paralegals in Immigration Law
SAN DIEGO, June 17, 2026 (GLOBE NEWSWIRE) — eimmigration by Cerenade, the leading immigration case management software trusted by 17,000 legal professionals, today announced the launch of Heroes Spotlight: Top Paralegals in Immigration Law. The recognition program was unveiled at the American Immigration Lawyers Association (AILA) Annual Conference, where nominations officially opened. Nominations are open…
-
Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470
Press Release Nicox Announces Positive Pre-submission Regulatory Feedback in China Supporting NDA filing for NCX 470 Exclusive licensee for China, Ocumension, received positive pre-submission regulatory feedback from the Chinese Center for Drug Evaluation (CDE) for NCX 470 Based on this feedback, Ocumension intends to proceed with the New Drug Application (NDA) submission in China Submission…
-
Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk
Press Release Atos joins CrowdStrike’s Project QuiltWorks to advance sovereign AI adoption and secure frontier AI risk Atos’ leadership at the intersection of cybersecurity, AI and digital sovereignty strengthens QuiltWorks’ ecosystem Paris, France – June 17, 2026 – Atos, a global leader of AI-powered digital transformation, today announces that it has joined CrowdStrike’s Project QuiltWorks.…
-
Resolution Therapeutics extends inflammatory and fibrotic disease pipeline with in vivo Regenerative Macrophage Therapy
Material Transfer Agreements provide access to leading lipid nanoparticle formulations to validate delivery of its proprietary payloads and accelerate development of in vivo Regenerative Macrophage Therapy Development programme complements Company’s autologous engineered Regenerative Macrophage Therapy, RTX001, in Ph 1/2 clinical development Together, programmes aim to broaden patient population able to benefit from Regenerative Macrophage Therapy…
-
Bond Announces Conversion of Outstanding Debt into Equity at Significant Premium to Market
June 16, 2026 08:07 ET | Source: Our Bond, Inc. Major Investor Exchanges Approximately $3.3 Million of Debt for Convertible Preferred Equity Priced at $2.0265 Per Common Share — a Premium of More Than 200% to Recent Trading Levels Above-Market Conversion Along With Separate Payment Schedule Adjustment Reduce 2026 Debt Burden By $4.3M, Reflecting Investors’…
-
Weston Family Foundation invests an additional $37 million to safeguard one of Canada’s most ecologically valuable and threatened ecosystems
The conservation initiative brings together Indigenous communities, ranchers, and conservation organizations to protect Canada’s critical prairie grasslands June 16, 2026 06:00 ET | Source: Weston Family Foundation TORONTO, June 16, 2026 (GLOBE NEWSWIRE) — The Weston Family Foundation just announced an additional $37 million in funding through the Weston Family Prairie Grasslands Initiative, strengthening and…
-
SoftServe Cuts AI Agent Deployment from Months to Four Weeks
New platform helps companies move AI agents out of test projects and into live operations, without building custom tools from scratch June 15, 2026 10:33 ET | Source: SoftServe, Inc AUSTIN, Texas, June 15, 2026 (GLOBE NEWSWIRE) — SoftServe, a digital engineering and technology services company, today released the SoftServe Agent Management Platform. It gives…
-
Polyrizon Advances NASARIX™ Development with Key Human Study to Characterize Nasal Residence Time and Support FDA Regulatory Pathway
June 15, 2026 08:05 ET | Source: Polyrizon Ltd. New performance and characterization study in collaboration with leading European medical center marks a critical milestone in the validation of the NASARIX™ allergy blocker’s protective barrier function Raanana, Israel, June 15, 2026 (GLOBE NEWSWIRE) — Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech…
-
Orbs Launches On-Chain Execution Infrastructure for Institutional Crypto Trading
TEL AVIV, Israel, June 14, 2026 (GLOBE NEWSWIRE) — Orbs, the decentralized Layer-3 blockchain infrastructure focused on advanced on-chain trading, today announced Orbs Institutional, a new offering that provides trading desks, OTC firms, treasuries, custodians and financial platforms with direct access to its on-chain execution infrastructure. The launch builds on technology that has processed more…
-
Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026
– Verekitug, administered once every three months, led to clinically meaningful improvements in nasal polyp score (NPS) in approximately 80% of participants – – Majority of verekitug-treated participants experienced clinically meaningful improvements across key secondary endpoints, including 72% in nasal congestion and 83% in CRSwNP total symptom score – WALTHAM, Mass., June 14, 2026 (GLOBE…
-
Rocket Doctor Grants Stock Options and RSUs
June 12, 2026 17:13 ET | Source: Rocket Doctor AI Inc. Vancouver, BC, June 12, 2026 (GLOBE NEWSWIRE) — Rocket Doctor AI Inc. ( CSE: AIDR , OTC: AIRDF , Frankfurt: 939 ) (“Rocket Doctor AI”) has granted an aggregate 47,013 stock options, exercisable at $0.71 per share and valid for a term of three…
-
Exploratory Efficacy Data Suggests Further Study of Peanut Tolerance with Oral Mucosal Immunotherapy (OMIT)
NEW YORK, June 12, 2026 (GLOBE NEWSWIRE) — Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food allergies, today announced the presentation of exploratory efficacy data from the Oral Mucosal Escalation Goal Assessment (OMEGA) Phase 1 safety trial at the 2026 Eastern Allergy…
-
Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule
STOCKHOLM, Sweden, June 11, 2026 (GLOBE NEWSWIRE) — Syncron, a global leader in intelligent aftermarket solutions, today announced that Nissan Africa, Middle East, India, Europe, & Oceania (AMIEO) has completed a full rollout of its parts pricing solution across 40 primary markets and more than 140 export markets, finishing ahead of schedule in Q1 2026…
-
Nova Leap Health Corp. Announces Results of Annual and Special Meeting of Shareholders
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES HALIFAX, Nova Scotia, June 10, 2026 (GLOBE NEWSWIRE) — NOVA LEAP HEALTH CORP. (TSXV: NLH) (“Nova Leap” or “the Company”), announced today that its shareholders voted in favour of all items of business brought before them at the Company’s annual and…
-
Patton Awarded Subcontract to Develop Source-Secure Fiber Optic Modules for U.S. Defense Applications
“This award reflects the growing importance of trusted, domestic supply chains in national security systems.” Bryan DuboisV.P. Special ProjectsPATTON GAITHERSBURG, Md., June 10, 2026 (GLOBE NEWSWIRE) — Patton®—a US-based electronics developer and provider of contract engineering and manufacturing services—today announced it has been awarded a subcontract to develop specialized, source-secure fiber optic transport modules in…
-
ARCPOINT ANNOUNCES APPOINTMENT OF PETER KENDALL AS INTERIM CHIEF EXECUTIVE OFFICER
June 09, 2026 19:00 ET | Source: ARCpoint Inc. GREENVILLE, South Carolina, June 09, 2026 (GLOBE NEWSWIRE) — ARCpoint Inc. (TSXV: ARC) (the “Company” or “ARCpoint”) announces that its Board of Directors has appointed Peter Kendall as Interim Chief Executive Officer of the Company, effective June 9, 2026. Mr. Kendall’s appointment remains subject to acceptance…
-
Bond Highlights Growing Recognition of its Preventative Personal Security for Both Employees and Families
June 09, 2026 08:07 ET | Source: Our Bond, Inc. Series of Opinion Pieces by Bond CEO Doron Kempel Across Consumer and Business Media Reflect a Shift from Reactive Emergency Response to 24/7 Preventative Personal Security Bond’s Platform Has Supported More Than 1.4 Million Security Service Requests, Including Over 10,000 Emergencies and Life-Saving Interventions NEW…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
The New Drug Application for LNZ100 in China was submitted September 2025 with approval anticipated in Q1 2027 June 07, 2026 19:30 ET | Source: LENZ Therapeutics, Inc. SAN DIEGO, June 07, 2026 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ, “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ® (aceclidine…
-
Astrall Dynamics Makes INTERSCHUTZ 2026 Debut with Hypertron-T01 Quadruped Firefighting Robot
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) — Astrall Dynamics demonstrated its Hypertron-T01 heavy-duty quadruped robot at INTERSCHUTZ 2026, demonstrating a complete, unmanned firefighting solution designed to support firefighters by performing high-risk tasks in hazardous zones. In active fireground scenarios, traditional robotic systems often force a critical operational trade-off: high mobility with limited payload, or…
-
Astrall Dynamics Showcases Unmanned Quadruped Firefighting Robot at INTERSCHUTZ 2026
HANOVER, Germany, June 07, 2026 (GLOBE NEWSWIRE) — Astrall Dynamics at INTERSCHUTZ 2026’s debut demonstrated its Hypertron-T01 heavy-duty quadruped robot. Positioned as a complete, unmanned firefighting solution, the system featured a live demo designed to support firefighters by performing high-risk tasks in hazardous zones. Traditional firefighting robots force an operational trade-off: high mobility with limited…
-
Her Bodhi Claims Evaluated: What Research Reveals About This Primal Queen Alternative, Weight Loss Support and Consumer Reviews
Editorial note: This article is an independent informational evaluation of publicly available product information. It is not medical advice, not a diagnosis or treatment recommendation, and not an endorsement of any brand. Dietary supplements are not medical devices and are not intended to diagnose, treat, cure, or prevent any disease, including menopause. Statements have not…
-
SlimTide Capsules [UPDATED WARNING 2026] Slim Tide Uncovering the Real Truth Behind the Trending Weight Loss Supplement
Largo, FL, June 06, 2026 (GLOBE NEWSWIRE) — SlimTide is a ketogenic support supplement created to help individuals pursuing weight-management goals through nutritional ketosis. The formula features a specialized blend of exogenous ketones designed to complement a low-carbohydrate lifestyle and support metabolic efficiency. SlimTide: A Complete Consumer Guide As obesity rates and lifestyle-related health concerns…
-
Bluejay Diagnostics Announces Closing of Up to $23.7 Million Private Placement Priced At-The-Market Under Nasdaq Rules
June 05, 2026 20:13 ET | Source: Bluejay Diagnostics, Inc. $8.5 million upfront with up to approximately $15.2 million of potential additional gross proceeds upon the exercise in full of warrants Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash,…
-
All-Round for Work & Play: KTC Dual-Mode Monitor H27P6 Adapts to Full-Scenario Needs
Houston, Texas, USA, June 05, 2026 (GLOBE NEWSWIRE) — I. Hybrid Work Fuels Rising Multi-Monitor Demand The growing prevalence of hybrid work is reshaping global professionals’ work and leisure habits. Recent research indicates remote work has driven a 28% uptick in multi-monitor adoption among U.S. knowledge workers; WFH users see the same 28% year-on-year rise…
-
NatureU® Now Has Three Clinical Studies Publicly Registered on ClinicalTrials.gov as 56-Day PQQ Skin-Aging Study (NCT07571629) Joins Two Previously Published Peer-Reviewed Trials
Kwun Tong, Kowloon, HK, June 05, 2026 (GLOBE NEWSWIRE) — The newly registered 56-day exploratory study of NatureU® Mind Care BeautyU Caps — reporting within-participant changes of −46.7% in crow’s-feet wrinkle count and +58.7% in stratum corneum hydration at Day 56 — joins NatureU’s prior sleep and satiety clinical trials, both already published in peer-reviewed…
-
Fangzhou Showcases AI-Powered Chronic Disease Management Solution With Tencent Health at Tencent Cloud Conference
BEIJING, June 05, 2026 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI‑driven Internet healthcare solutions, attended the 2026 Tencent Cloud AI Industry Applications Summit in Beijing, where it showcased its “AI + Chronic Disease Services” digital solution developed in collaboration with Tencent Health. The conference, themed “Agent…
-
Chiesi Global Rare Diseases Announces European Commission Approval of LOJUXTA® (lomitapide) ▼ Capsules for Paediatric Use in Homozygous Familial Hypercholesterolaemia (HoFH)
European Commission approval expands the indication of lomitapide in the European Union (EU) to include children 5 years of age and older with HoFH, an ultra-rare genetic disorder affecting LDL-cholesterol levels June 05, 2026 02:00 ET | Source: Chiesi Global Rare Diseases PARMA, Italy, June 05, 2026 (GLOBE NEWSWIRE) — Chiesi Global Rare Diseases, a…
-
Crypto Market News: AlphaPepe To Announce First CEX Partnership as XRP Price Prediction Hits $8.00
MONACO, June 04, 2026 (GLOBE NEWSWIRE) — Crypto market news is turning toward AlphaPepe after the project confirmed that its first centralized exchange partnership reveal is now expected within weeks. The presale has crossed $1.46 million in total capital raised, Stage 17 is live at $0.01858, and holder growth has climbed past 9,200 while AlphaSwap…
-
Impact Analytics Releases “The Retail Demand Reset” Report, Warning of $5B+ Annual Capital Exposure as GLP-1 Adoption Reshapes Apparel Economics Across Sizing and Assortment
NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) — Impact Analytics today announced the release of their latest research report, The Retail Demand Reset: How GLP-1 Adoption Is Reshaping Apparel Economics, From Size Curves to Assortment Architecture, Capital Allocation, and Sustainability Risk. Report findings were featured in the Wall Street Journal. Building on the company’s 2024 and…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Alvotech announces resubmission of U.S. Biologics License Applications for AVT05, a proposed biosimilar to Simponi® and Simponi Aria®, and AVT06, a proposed biosimilar to Eylea®
REYKJAVIK, Iceland, June 4, 2026 – Alvotech (NASDAQ: ALVO; ALVO-SDB), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today announced the resubmission to the U.S. Food and Drug Administration (FDA) of Biologics License Applications (BLAs) for AVT05, a proposed biosimilar to Simponi® and Simponi Aria® (golimumab), and AVT06,…
-
Sword Group: Strategic contract with eu-LISA
Sword Group | eu-LISA framework contract awarded to leading consortium Sword ranked first in a €93 million contract for the EU Entry/Exit System Sword Services Greece, leading a consortium alongside Netcompany and Sopra Steria, has been ranked first and awarded a contract under eu-LISA’s Dynamic Purchasing System for the development and maintenance of the Entry/Exit…
-
It’s Not a Prenatal Class, It’s a Social Club With a Curriculum for Parenthood — Launching in Miami This August
MIAMI, June 03, 2026 (GLOBE NEWSWIRE) — Miami has attracted transplants, globally mobile families, and ambitious young professionals who are building lives far from the support systems they grew up with. At the same time, lifelong Miami families are navigating parenthood in a city that can often feel fast-paced, disconnected, and isolating during one of…
-
Noah Medical Appoints Dr. Krish Bhadra as Chief Pulmonary Advisor
Pioneering Physician and Interventional Pulmonology Innovator Joins Noah Medical to Accelerate the Next Era of Robotic-Assisted Lung Cancer Diagnosis and Treatment June 03, 2026 08:00 ET | Source: Noah Medical SAN CARLOS, Calif., June 03, 2026 (GLOBE NEWSWIRE) — Noah Medical, a medical robotics company dedicated to earlier, more accurate lung cancer diagnosis, announced the…
-
Pure DC Demonstrates Gas Connected Data Centres can be Decarbonised at Operational Scale with Europe’s First Large-Scale Cross-Border Biomethane Deal
Pure DC’s Dublin site decarbonised with biomethane from Germany Transaction is a 9,000-fold increase on its 2025 Proof of Concept 9GWh of RED II & III-compliant biomethane balanced from Germany to Ireland and consistent with Ireland’s Large Energy User policy and Climate Action Plan LONDON, June 03, 2026 (GLOBE NEWSWIRE) — Pure Data Centres Group…
-
Francisco Ranzi Müller Leads the MicAi-X Technology Upgrade, Bringing Automated Trading Capabilities Into a New Cycle
SAN DIEGO, June 03, 2026 (GLOBE NEWSWIRE) — Recently, the automated trading program service platform MicAi-X has officially launched a new round of platform system upgrade plan. Founder and IT team leader Francisco Ranzi Müller will lead the relevant technical planning and system optimization efforts. This upgrade is regarded as a key milestone for MicAi-X…
-
Jersey College Offers Associate Degree for NJ Nursing Students With and Without Prior Licensure
Teterboro and Ewing campuses offer full ADN program. Next class starts August 17. June 02, 2026 10:05 ET | Source: Jersey College TETERBORO, N.J., June 02, 2026 (GLOBE NEWSWIRE) — Jersey College, the institution dedicated to excellence in nursing education, provides an Associate Degree in Nursing program at its Teterboro and Ewing, N.J., campuses, offering…
-
MAPS Publishes First-of-Its-Kind Literature Review on Psychedelic Healing for People Impacted by the Criminal Legal System
“Relocating the Root” is a scoping literature review on the mental health needs of people directly impacted by the criminal legal system Publishing this literature review launches a project that builds on nearly four decades of MAPS advocacy by turning the lens of psychedelic research toward people directly harmed by the war on drugs MAPS…
-
Gaxos Secures Additional Funding from Amazon AWS to Accelerate AI Sales Platform Development
June 02, 2026 08:12 ET | Source: GAXOS.AI INC. Roseland, NJ, June 02, 2026 (GLOBE NEWSWIRE) — Gaxos.ai Inc. (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various high-growth sectors, today announced that Amazon Web Services (“AWS”) has committed additional funding to accelerate Gaxos Labs’ AI-powered sales coaching platform. The additional AWS…
-
J-Star Holding Provides Additional Details on Baytown Economic Development Foundation LOI Supporting Proposed U.S. Solid-State Battery Manufacturing Facility
Formal LOI Details Site Selection Support, Infrastructure Requirements, 18-Month Site Availability Commitment, and Framework for Long-Term Facility Development June 01, 2026 11:50 ET | Source: J-Star Holding Co., Ltd TAICHUNG CITY, Taiwan, June 01, 2026 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today provided additional details regarding the commitment…
-
Zealand Pharma – Transactions related to share buy-back program (week 22, 2026)
Company announcement No. 20 / 2026 Zealand Pharma – Transactions related to share buy-back program (week 22, 2026) Copenhagen, Denmark, June 1, 2026 – Zealand Pharma A/S (“the Company” or “Zealand Pharma”) (Nasdaq: ZEAL) (CVR-no. 20045078), a biotechnology company transforming the future of metabolic health, today reports transactions related to its share buy-back program (the…
-
Melt Drops [URGENT REPORT 2026] MeltDrops Shocking Boom Why Everyone Is Talking About This Weight Loss Supplement
New York City, NY, May 31, 2026 (GLOBE NEWSWIRE) — In an era where consumers are increasingly seeking convenience, sustainability, and innovation in the products they buy, a new category of compact, dissolvable products known as “Melt Drops” is drawing attention from retailers, industry experts, and consumers alike. Transform your wellness routine with Melt Drops…
-
Crypto News Today: AlphaPepe Hits $1.38M Raised While Bitcoin Price Prediction Targets $250K
MONACO, May 30, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward AlphaPepe after the project announced that its presale has crossed $1.38 million in total capital raised. Stage 17 is live at $0.01804 per token, the holder count has passed 9,000, the AlphaSwap AI DEX demo has surpassed 5,000 active users, and AlphaPepe…
-
Nokia Corporation – Managers’ transactions (Hanrahan)
May 31, 2026 06:00 ET | Source: Nokia Oyj Nokia CorporationManagers’ transactions31 May 2026 at 13:00 EEST Nokia Corporation – Managers’ transactions (Hanrahan) Transaction notification under Article 19 of EU Market Abuse Regulation.____________________________________________Person subject to the notification requirementName: Hanrahan, VictoriaPosition: Other senior manager Issuer: Nokia CorporationLEI: 549300A0JPRWG1KI7U06Notification type: INITIAL NOTIFICATIONReference number: 158758/5/6____________________________________________Transaction date: 2026-05-26Venue: XNYSInstrument…
-
Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC
Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLC Plasma MET test showed high concordance with tissue IHC/FISH in EGFR-mutated NSCLC following progression on first-line targeted therapy (AUC=0.97) Baseline and longitudinal profiling in METex14 skipping NSCLC identified biology associated with therapeutic…
-
Immatics Presents Data on IMA401 MAGEA4/8 Bispecific at 2026 ASCO Annual Meeting with Simultaneous Publication in Nature Medicine Supporting Development of IMA401/IMA402 Combination in Lung Cancer
IMA401 achieved deep and durable responses in various indications, including melanoma and head and neck cancer, with an initial promising clinical signal observed in lung cancer In head and neck cancer, IMA401 treatment at recommended Phase 2 dose (RP2D) with or without pembrolizumab resulted in a 29% confirmed ORR (4/14), 64% DCR (9/14) and mDOR…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
